Hypertension
Clinical research in hypertension centered on blood pressure control in obese patients, with interest in therapeutic strategies that address sustained arterial pressure reduction and ambulatory blood pressure monitoring.
- Antihypertensive therapy
- Obesity-related hypertension
- 24-hour ambulatory blood pressure
The sponsor’s activity is focused on comparative cardiovascular treatment approaches within a single-site clinical setting in Athens, with attention to patients requiring targeted management of elevated blood pressure.
Cardiovascular Medicine
Research interests extend to cardiovascular medicine, particularly the selection of blood pressure–lowering strategies relevant to patients with metabolic risk factors and persistent vascular load.
- Vascular risk reduction
- Blood pressure management
- Metabolic cardiovascular risk
The sponsor is engaged in clinical evaluation of therapeutic options used in routine cardiovascular care, with emphasis on measurable hemodynamic outcomes.
Renal and Endocrine-Related Vascular Care
Given the organisational focus on vascular, heart, brain, and kidney conditions, the research profile includes interest in renal and endocrine-related vascular aspects of hypertension, especially in patients where organ protection is clinically relevant.
- Kidney-related hypertension
- Mineralocorticoid receptor antagonism
- Renin-angiotensin system therapy
The funded work aligns with therapeutic choices commonly used to manage vascular and renal consequences of high blood pressure.
